The aryl hydrocarbon receptor (AHR) is known for its roles in xenobiotic metabolism and essential physiologic processes such as cell growth, death, and differentiation. AHR is also an important regulator of male reproductive processes. However, no studies have characterized the consequences of loss of AHR in spermatogenesis. We used Ahr knockout (Ahr−/−) mice to assess the effects of loss of AHR on the architecture and gene expression of the seminiferous epithelium and functional sperm outcomes. The histopathological defects of the Ahr−/−seminiferous epithelium included vacuoles, multinucleated giant cells, hypocellularity with widened intercellular spaces, apical sloughing, and an excess number of retained elongated spermatids. Quantitative real-time PCR revealed significant down-regulation of Testin and Magea4, indicating Sertoli cell and spermatogenic dysregulation. Moreover, the reduced expression of Hspa2, Prm1, and Prm2 as well as decreased expression of Nrf2, Sod2, and Ucp2 suggested poorly remodeled germ cells with increased vulnerability to oxidative stress. In wild-type sperm, AHR protein was localized to the acrosome and the principal piece of the mature sperm flagellum. The in vitro fertilization rate was significantly lower with Ahr−/− sperm as compared to wild-type sperm, and there were morphologic abnormalities of the Ahr−/− sperm head and tail. Taken together, our data indicate that AHR plays an important role in normal sperm development.
INTRODUCTION
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that, upon binding to a natural or synthetic compound, translocates to the nucleus, binds to the AHR nuclear transporter (ARNT), and induces expression of many genes [1]. AHR is best known for induction of the cytochrome P450 superfamily of genes (Cyp1a1 and Cyp1a2) and the detoxification of endogenous and exogenous ligands [2, 3].
AHR binds with high affinity and specificity to dioxin-like compounds, which are highly toxic and widely dispersed environmental hazards formed via industrial processes such as incineration and the incomplete combustion of fossil fuels [4, 5]. Exposure to dioxin-like compounds is associated with an array of adverse health effects such as cancers, immune system dysregulation, and endocrine disruption [6, 7]. Additionally, reproductive sequelae of exposure to dioxin-like compounds have been suggested by the prevalence of cardiac defects, cleft palate, renal agenesis, and neural tube defects in the children of male firefighters [8] and veterans of Gulf War I [9] and the Vietnam War [10]. Increased rates of cardiac defects [11], decreased sperm counts and motility, and abnormal sperm morphology were also among the consequences of smoking cigarettes [12]. Whereas coculture of human sperm with benzo(a)pyrene (BP) produced premature acrosome reactions and accelerated hyperactivation, BP-exposed human males were found to have dysmorphic sperm and reduced sperm counts [13]. Similarly, wild-type mice exposed to daily BP exhibited low sperm counts and subfertility that extended to subsequent generations [14]. Moreover, mice lacking indoleamine 2,3-dioxygenase have significant increases in proinflammatory markers and in the number and percentage of morphologically abnormal sperm. Indoleamine 2,3-dioxygenase is the rate-limiting enzyme in the conversion of dietary tryptophan to kynurenic acid, which has an affinity for AHR that is comparable to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) [1516–17]. Although no direct mechanisms have been identified, collectively these findings suggest that either the absence of AHR ligand binding or AHR activation may result in inflammation, apoptosis, and oxidative stress in sperm leading to DNA damage [18, 19].
Despite the reproductive effects noted above, the role of AHR in spermatogenesis has received little attention. Normal cellular processes, such as the cell cycle, stem cell proliferation, and tissue differentiation, are regulated by AHR, and AHR is expressed in tissue-specific and developmental stage-specific patterns [20]. AHR expression in the seminiferous tubule was explored in the rat, where it was found to be restricted to the primary pachytene spermatocytes during stages VII–XI and round spermatids during stages II–XIV of the spermatogenic cycle. In contrast AHR and ARNT were expressed in all seminiferous tubule stages of the human testes [21]. Although male fertility, sperm count, seminal vesicle weight, and dorsolateral prostate weights are all decreased in Ahr-deficient mice in an age-dependent manner [2223–24], no studies have documented the histological and gene expression consequences of Ahr loss of function on spermatogenesis. Here we have used the Ahr knockout (Ahr−/−) mouse to gain insight into the role of AHR during spermatogenesis and fertilization.
MATERIALS AND METHODS
Animals and Tissue Sampling
All the animal procedures were approved by both the Animal Studies Committee at Washington University in St. Louis and the Institutional Animal Care and Use Committee at the VA St. Louis Health Care System and were conducted in accordance with the specifications of the Taconic Farms (Hudson, NY) material transfer agreement. All the assays used 8–10 wk old C57BL/6J Ahrb-1 (WT) (Jackson Laboratories) and age-matched C57BL/6-Ahrtm1.2Arte homozygous Ahr deletion (Ahr−/−) male mice (Taconic Farms). The Taconic Ahr−/− mouse has a complete deletion of exon 3 that results in out of frame splicing and the absence of AHR functional protein. WT females that were 4-wk old were used as oocyte donors for in vitro fertilization (IVF). The animals were maintained on a 12L:12D cycle with free access to food and water.
Histology and Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick-End Labeling
Testes were fixed in Bouin solution, embedded in paraffin, and cut into 5-μm thick sections followed by hematoxylin and eosin (H&E) staining. For terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL), sections were deparaffinized in xylene for 15 min, rehydrated in ethanol grades, and hydrated in distilled water for 5 min. Sections were then treated with proteinase K (20 μg/ml) for 30 min at room temperature, rinsed with PBS and processed to detect fragmented DNA by using the In Situ Cell Death Detection Kit (Roche Diagnostics) according to the manufacturer's directions. Nuclei were counterstained with To-Pro 3 (1:500; Life Technologies) for 3 min. Label solution without terminal transferase was used for the negative control. The number of TUNEL-positive cells within the seminiferous tubule cross-sections was counted to determine the incidence of apoptosis in the WT and Ahr−/− testes. Because fewer than nine apoptotic cells typically occur in the WT seminiferous tubule cross-sections [25], the prevalence of TUNEL-positive seminiferous tubules was represented as a percentage of the total number of seminiferous tubules with more than nine TUNEL-positive cells per seminiferous tubule cross-section. Approximately 500 to 600 tubules were counted per animal.
RNA Isolation and cDNA Synthesis
Testes were dissected and immediately immersed in optimal cutting temperature compound surrounded by dry ice and isopenthane and stored at −80°C. Total RNA was extracted with Trizol reagent (Life Technologies). RNA quantity and quality were confirmed via Nanodrop. RNA samples with 260 nm:280 nm ratios ≥1.8 were used for further analysis. RNA was reverse transcribed by using the QuantiTect reverse transcription kit (Qiagen) according to the manufacturer's recommendations.
Quantitative Real-Time PCR Analysis
Relative quantification of gene expression was determined via quantitative real-time PCR (qRT-PCR) by using the ABI 7500 fast and TaqMan gene expression assays (Applied Biosystems, Inc.) in accordance with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines [26]. Expression of each candidate gene, no-template control, positive control, and the endogenous reference gene β-actin [27, 28] was analyzed by using equal amounts of input template. Complementary DNA prepared from adult mouse whole testis RNA (Agilent) was used for serial dilutions and standard curve analysis of each target gene and β-actin to ensure amplification efficiencies of 95% to 100%. The cDNA, 100 nM of gene-specific primers, and the TaqMan probe mix were amplified as follows: 95°C for 20 sec, then 40 cycles of 3 sec at 95°C and 30 sec at 60°C. Changes in gene expression were analyzed via relative quantification, and ΔCt was calculated by subtracting the mean Ct of the endogenous controls from the Ct of the WT (reference samples) and Ahr −/− target genes. The value for ΔΔCt was ascertained through the subtraction of the WT ΔCt from the ΔCt of the Ahr−/− target genes with WT (reference samples) values being set to one. Fold changes were calculated via 2−ΔΔCt. With the exception of spermatogenic-specific genes such as Melanoma antigen family A4 (Magea4), Testin, heat shock protein 2 (HspA2), and the protamines, WT liver was used as the positive tissue control. The representative genes, corresponding TaqMan assay ID numbers, and amplicon sizes appear in Table 1.
TABLE 1
TaqMan assays used for qRT-PCR analysis.
Sequence Analysis
DNA sequence for ∼10.4 kb upstream of mouse Testin, and ∼5.5 kb upstream of mouse Magea4, including the genes, was extracted from the UCSC Genome Browser ( http://genome.ucsc.edu/) [29] and searched for the AHR response element (AHRE) core consensus site 5′-T/NGCGTG-3′ [30] in DNASTAR Seqbuilder v11.0.
Western Blot Analysis
Proteins were extracted from caudal sperm, liver, testes, and epididymis and analyzed by Western blot analyses according to standard procedures. The primary antibodies were anti-AHR (1:1000; Enzo Life Sciences), anti-MAGEA4 (1:1000; Sigma), and anti-TESTIN (1:1000; Protein Tech). Horseradish peroxidase-conjugated goat-anti-rabbit, goat-anti-mouse, or donkey anti-goat secondary antibodies (1:15 000; Santa Cruz Biotechnology) and Super Signal West Femto Maximum Sensitivity Chemiluminescence Substrate (Thermo Scientific) were used for detection. The loading control was β-tubulin (1:1000; Santa Cruz Biotechnology).
AHR Immunofluorescence
Four different anti-AHR antibodies and several different fixation conditions were tested to identify a method that resulted in minimal nonspecific staining in testes from Ahr-null mice. Testes were fixed in modified Davidson fixative, embedded in paraffin, cut into 5-μm thick sections, deparaffinized, and rehydrated. After antigen unmasking with 10 mM sodium citrate, pH 6.0, sections were blocked at room temperature for 30 min in 5% nonfat dry milk powder in Tris-buffered saline (50 mM Tris-Cl, pH 7.5, 150 mM NaCl [Sigma]). The sections were incubated overnight at 4°C with rabbit polyclonal anti-AHR (1:50; Enzo Life Sciences), incubated for 1 h with the Alexa Fluor 488 goat-anti-rabbit (1:400; Life Technologies), and incubated for 5 min with Sytox Orange (1:1000; Life Technologies) as the counterstain.
Sperm from the cauda epididymis were allowed to swim freely for 15 min in VitroFert Cook Medical), transferred to microtubes, and pelleted for 5 min at 500 relative centrifugal force. After resuspending the pellets in 5 ml of VitroFert, the sperm were allowed to swim up for 45–60 min at 37°C under 5% CO2 incubation. The supernatant was then collected, pelleted, and applied to slides. The slides were fixed for 3 min at room temperature in 4% paraformaldehyde, blocked for 1 h in bovine serum albumin and normal goat serum, permeabilized in Triton X-100 and PBS for 30 min, and washed with PBS. Primary and secondary antibody incubation was completed as described above, and TO-PRO 3 (1:500; Life Technologies) was used as the nuclear counterstain. Negative controls, without primary antibodies, were used to confirm nonspecific reactions.
Oocyte Retrieval, Sperm Preparation, and IVF
A 1:5 male to female ratio of 8- to 10-wk-old WT or age-matched Ahr−/− males and 4-wk-old WT superovulated (Jackson Laboratories) females was used for IVF. Superovulation occurred via a one-time intraperitoneal injection of 5 international units of pregnant mare serum gonadotropin, followed by 5 international units of human chorionic gonadotropin (HCG) 48 h later. At 12–13 h post-HCG injection, sperm were prepared from appropriate males as follows: the testes and epididymis were quickly dissected, the testes snap frozen, and the sperm recovered from the cauda epididymis. A few incisions were made in the cauda epididymis, and the sperm were gently teased out. A fraction of the sperm was removed for immunofluorescence, morphology analysis (Spermac stain; FertiPro, N.V.), or computer-assisted semen analysis (Hamilton-Thorne Research) to determine motility and average concentration. Sperm were capacitated by incubating in 500 μl of VitroFert (Cook Medical) for 90 min at 37°C under 5% CO2. At 14–15 h post-HCG injection, the oviducts were dissected, the cumulus oocyte complexes were removed from the ampulla, and a standardized aliquot (<10 μl of 2 × 106 sperm/ml) of sperm was added to the insemination dish. After 4–6 h, the fertilized oocytes were triple washed in EmbryoMax Potassium Simplex Optimized Medium with 1/2 Amino Acids (Millipore Corporation) and incubated at 37°C in a 5% CO2, 5% O2, 90% N2 modular incubator (Billups-Rothenberg). Two-cell (fertilization rate) and Embryo Day 3.5 blastocyst rates were determined by counting. No embryos were transferred into recipient females.
Sperm Morphology
Sperm were collected as described above and allowed to swim freely in VitroFert for 5 min at 37°C under 5% CO2 incubation. Spermac (SPS050; FertiPro, N.V.) fixative and stain were used according to the manufacturer's directions. The slides were viewed under 400× and 1000× oil immersion by one primary unblinded reviewer and two independent blinded reviewers. One hundred sperm were counted per slide per animal for a total of 300 WT sperm and 300 Ahr −/− sperm. Morphology was classified as normal or abnormal on the basis of the characteristics of the head and tail, or the presence of a cytoplasmic droplet [31]. Abnormalities were counted as aggregate percentages.
Statistical Analyses
For qRT-PCR data, mean threshold cycle (Ct) values were analyzed relative to the mean (CT) of the endogenous control β-actin to generate ΔCt, which was subsequently normalized to one (WT) as the reference sample to generate ΔΔCt. The results were then log transformed (2−ΔΔCt) and presented as ± fold change. Quantitative real-time PCR data are presented as the mean ± SEM of four independent experiments, each assayed in duplicate. Statistical significance of the qRT-PCR data was determined via one-way ANOVA (nonparametric) with 95% confidence intervals. The fertilization percentage was determined by dividing the number of two-cell embryos by the number of ova. The percent of two-cell embryos that developed into blastocyst-stage embryos was calculated by dividing the number of blastocysts by the number of initial two-cell embryos. Reproductive data and organ weights are expressed as the mean of three independent experiments. Differences were analyzed by using unpaired t-tests; P < 0.05 was considered statistically significant. Sperm morphology and immunofluorescence were verified by independent observation.
RESULTS
The AHR Is Required for Normal Spermatogenesis
Because of the comparatively stable testis weight within a species [32], a significant increase or decrease in reproductive organ weights may reflect damage to the seminiferous epithelium and be indicative of an adverse reproductive effect. When compared to WT control, the reduced body weight and relative testis to body weight in the Ahr−/− males were nonsignificant. In comparison, the reduced weights of the Ahr−/− testis, epididymis, and cauda epididymis weights were highly significant with P-values of 0.004, 0.003, and 0.009, respectively. The relative epididymis to testis weight (30.4% ± 0.6% vs. 37.2% ± 1.9 %) was also significantly lower (P < 0.05) in Ahr−/− when compared to WT controls (Table 2). Given the alterations in the reproductive organ weights, we completed a thorough histopathological evaluation of the seminiferous epithelium and observed a number of abnormalities in those from Ahr−/− males (Fig. 1). H&E staining of the stages VII–VIII Ahr−/− cross-sections revealed hypocellularity with widened intercellular spaces, multinucleated giant cells, and vacuoles suggesting missing germ cell stages (Fig. 1A). The cleavage of spermatocytes from round spermatids was also noted in the stages VII–VIII Ahr−/− cross-sections (Fig. 1C), which was consistent with sloughing of the apical region of the seminiferous epithelium. At stage XII, there were excess numbers of retained spermatids in the basal compartment of the seminiferous epithelium of the Ahr−/− mice (Fig. 1E), which suggested the failure of spermatids to disengage during spermiation [33]. Widened intercellular spaces were again noted at stages IV–VI of the H&E stained Ahr−/− cross sections (Fig. 1E). Collectively, these findings were indicative of seminiferous epithelial degeneration, disrupted germ cell attachment, insufficient structural support, and the failure of the spermatids to detach from the Sertoli cells during spermiation.
TABLE 2
Absolute and relative body and reproductive organ weights.
*
All the values are mean ± SEM.
To examine whether there was excess cell death in the Ahr−/− testes, we used TUNEL to examine the numbers of apoptotic cells. Compared to WT, there was a significant increase (P < 0.05) in the percentage of TUNEL-positive seminiferous tubules (64% vs. 3%) in the Ahr−/− cross-sections (Fig. 2, A and B).
Gene Expression Changes in Testes Lacking AHR
To confirm that the Ahr−/− mice did not express Ahr in the testis and to examine the expression of other genes in the classic AHR pathway, we performed qRT-PCR on RNA isolated from Ahr−/− and WT testes, epididymis, and caudal sperm. The WT liver was the positive tissue control. As expected, Ahr was significantly down-regulated in all Ahr−/− tissues examined. There was a 32-fold reduction in Ahr when compared to WT testes (Fig. 3A). We also examined the expression of two transcriptional targets of AHR, AHR repressor (Ahrr) and Cyp1A1, and found that expression of these genes was undetectable in WT caudal sperm or the epididymis. Ahrr and Cyp1A1 were expressed at a significantly lower level in testes from Ahr−/− mice than in testes from WT mice (Fig. 3, B and C). By contrast, expression of Hsp90αα1, which is a subclass of Hsp90α and encodes a chaperone protein for a variety of proteins, including AHR [34], but is not a known transcriptional target of AHR, was unaffected by loss of Ahr in the liver and whole testes but was lower in sperm (Fig. 3D). Hsp90α homozygous mutant mice were also reported to be sterile with defects in spermatogenesis [35]. While there are two subclasses of Hsp90a, the functions are rarely differentiated. Because the expression of Hsp90aa1 surpassed that of Hsp90aa2 in all spermatogenic cell stages [35, 36], Hsp90aa1 was selected as the isoform for this study.
To begin to understand why loss of AHR led to the defects we observed in seminiferous tubules, we examined expression levels of candidate genes involved in cell cycle regulation and cell-cell adhesion. Because the seminiferous epithelium accounts for 80% of the weight of the adult testis [37], whole testis mRNA was used as a surrogate marker of gene expression in seminiferous epithelium. Magea4 is a growth-promoting gene that inhibits cell cycle arrest and p53-mediated apoptosis [38] and that is completely silent in normal tissues with the exception of type A and B spermatogonia, some tumor cells, and the placenta [3940–41]. Magea4 expression was 4-fold lower in Ahr−/− testes (P < 0.05) than in WT testes. We next examined the expression of P21, which is a negative regulator of the cell cycle, is weakly expressed in spermatocytes and spermatids, and is induced by AHR activation [42]. However, expression of P21 was not significantly affected by the loss of AHR in the testis (not shown), suggesting that cell cycle regulation was intact. Finally, consistent with the idea that the histological defects we observed were due to Sertoli cell degeneration, Testin, a specific marker of Sertoli cell and germ cell adhesion [43], was more than 100-fold lower in Ahr−/− testes (P < 0.01) than in WT testes (Fig. 4),
Because depleted germ cells typically cause a physiologic surge of TESTIN [44] and the dramatic down-regulation of Testin was inconsistent with the histopathology, we therefore wondered whether Testin was regulated by AHR. Using the UCSC genome browser [29], we found 35 core AHRE within 9 kb of the Testin start site and two AHRE (−73 and −54) located within the region (−425 to + 58) of maximal Testin promoter activity [44]. The presence of multiple copies of AHRE suggested the possibility that Testin is highly regulated by AHR. Conversely Magea4 contains only one AHRE at position +590 in this single exon gene.
Given the histological abnormalities in the Ahr−/− seminiferous tubules, we examined the expression of genes that are expressed during spermiogenesis. Prm1 and Prm2 encode protamines, which replace histones late in spermatogenesis and are responsible for sperm head condensation. Hspa2 encodes a heat shock protein that is expressed exclusively in spermatogenic cells (reviewed in [45]) and is a chaperone of transition proteins that precede protamination. Disrupted HSPA2 is associated with poorly remodeled germ cells with residual mitochondria that generate increased reactive oxygen species [46]. All three of these genes were expressed at lower levels in Ahr−/− testes than in WT testes (Fig. 5).
Because activation of AHR causes oxidative stress, we examined the expression of several genes involved in response to this insult. Uncoupling protein 2 (UCP2) controls the formation of mitochondrial reactive oxygen species [47], superoxide dismutase (SOD, encoded by Sod1 and Sod2), rapidly converts the superoxide free radical to hydrogen peroxide for rapid elimination [18], and the transcription factor NRF2 coordinates the rapid cellular response to oxidative stress [48]. Ucp2, Sod2, and Nrf2 were all expressed at lower levels in Ahr−/− testes than in WT testes (Fig. 6). Taken together, our gene expression studies suggest the presence of poorly remodeled germ cells with increased vulnerability to oxidative stress in Ahr−/− mice.
The AHR Is Required for Proper Sperm Morphology and Function
Because oxidative stress is thought to play a significant role in DNA damage in sperm and thus may affect fertilization [18], we next asked whether the histological and gene expression abnormalities we observed in the testis corresponded with defects in mature sperm. We first isolated caudal sperm from WT and Ahr−/− mice and used qRT-PCR to confirm that Ahr and Hsp90αα1 are expressed in WT sperm and demonstrate that expression of these genes is significantly decreased in Ahr−/− sperm (Fig. 3). Subsequent immunofluorescence analysis revealed that AHR localized to the acrosome and the principal piece of the sperm flagella in WT sperm when compared to the Ahr−/− sperm (Fig. 7). AHR disappeared from the WT sperm acrosome postcapacitation (data not shown). While the mean background rate of abnormal sperm in this study was 30.5%, the prevalence of abnormalities in the Ahr−/− sperm approached 42.6% (Fig. 8), Abnormalities included flattening of the base of the head, loss of the typical hook-shaped head, changes in the flagellum such as a folded or coiled tail, and the presence of a cytoplasmic droplet [31]. Sperm concentration and sperm motion parameters were then quantified by computer-assisted sperm analysis. Sperm count, average motility, and progressive motility were not significantly different between Ahr−/− and WT mice (Table 3).
TABLE 3
Computer-assisted semen analysis parameters and fertility measures.
a
Values are means ± SEM.
b
Fertility defined as percentage of ova that developed into two-cell embryos.
c
Blastocyst formation defined as percentage of two-cell embryos that developed into blastocysts.
To determine whether Ahr−/− sperm were functional, we performed IVF with oocytes from WT females. IVF is ideal because of the ability to eliminate the influence of seminal fluid factors and analyze pure sperm populations devoid of somatic cell contamination; any differences that are seen are thus unambiguously sperm-specific. The mean IVF rate (as measured by formation of two-cell embryos) was significantly lower (P < 0.05) with sperm from Ahr−/− males than with sperm from WT controls (48.6% vs. 80.6%). In contrast, the progression of two-cell embryos to blastocyst-stage embryos from the Ahr−/− males was significantly higher (P < 0.05) when compared to WT controls (Fig. 9).
Protein Expression in WT and Ahr−/− Testes
Modified Davidson was the preferred fixative, and rabbit polyclonal anti-AHR generated reproducible results. We were able to demonstrate that, in testes from WT mice, AHR was located in the Sertoli cell nucleus lying near the basement membrane, in the interstitium, and in the cytoplasm of the round spermatids. Additionally, we observed intense staining in the lumen of the seminiferous tubules as well as linear filamentous staining, suggesting the presence of AHR in the tail of the elongated spermatids (Fig. 10). To assess this possibility, we stained caudal spermatozoa and found that AHR localized to the acrosome and the principal piece of the sperm flagella in WT sperm (Fig. 7). AHR disappeared from the WT sperm acrosome postcapacitation (data not shown).
Because we observed some background AHR staining in the seminiferous tubules from Ahr−/− mice, we performed Western blot analyses to confirm that the protein was absent in the mutants. Consistent with the staining of caudal sperm (Fig. 7), we observed a faint band of the expected size (97 kDa) in extracts from WT caudal sperm. Additionally, we demonstrated that AHR is expressed in the testis, epididymis, and liver of WT males (Fig. 11). The lack of detectable bands in the corresponding samples from Ahr−/− mice indicates that the staining we observed in seminiferous tubules from Ahr−/− mice was nonspecific. Western blot analysis also confirmed that TESTIN and MAGEA4 protein was also reduced in testis from Ahr−/− mice (Fig. 11).
DISCUSSION
This study is the first to show that AHR is important to the structure and function of the seminiferous tubules. Our histological observations demonstrated that testes from Ahr−/− mice have significant architectural distortions at stages IV–XII of the seminiferous epithelium. The phenotypes we observed are suggestive of significant seminiferous epithelial degeneration and compromised Sertoli cell function. Sertoli cells extend from the basal lamina to the lumen of the seminiferous tubules to maintain direct and interactive contact throughout spermatogenesis until the detachment of the spermatozoa at spermiation [49]. Similar abnormal phenotypes (such as those described in this model) have been observed in the testes of mice exposed to mono-2-ethylhexyl phthalate, a male reproductive toxicant that selectively targets Sertoli cells and creates vacuolization and seminiferous epithelial disorganization, resulting in spermatocyte and spermatid degeneration [50]. In this study, AHR was observed in a Sertoli cell nucleus. This conforms to earlier reports of AHR immunoreactivity in Sertoli cells in the rat and human testes [21] and provides a mechanism whereby AHR ligands disrupt Sertoli cell functions. A single injection of TCDD led to widened spaces between germ cells and Sertoli cells in mice [23]. Additionally, the in vitro treatment of Sertoli cells with TCDD for 24 h led to the down-regulation of Testin and induction of Cyp1A1, which provided evidence of the activation of the AHR-signaling pathway [22, 51]. While it is seemingly inconsistent that both AHR loss of function, as described in this study, or AHR activation can down-regulate Testin, the latter can potentially be explained by the rapid AHR protein degradation (half life of 3 h) that occurs in the presence of intense and continuous AHR ligand activation [52]. When considered within this context, the dramatic down-regulation of Testin coupled with multiple AHREs in the Testin promoter region and the histopathology of the Ahr−/− seminiferous tubule cross-sections support the conclusion that AHR modulates Sertoli-germ cell interactions. In addition to Sertoli cell defects, the results of our gene expression studies suggest that there are germ cell defects in Ahr−/− mice. The down-regulation of Magea4 suggested reduced spermatogonial proliferation, and the reduced expression of HspA2, Prm1, and Prm2 indicate a defect in mature germ cell formation. Furthermore the single copy of AHRE within Magea4 suggests that AHR may act as a coregulator but not as a transcriptional regulator.
AHR expression patterns in the testes are also species-specific and developmentally driven, with some seminiferous tubule stages completely devoid of AHR staining [7, 21]. While this was not unexpected, it complicated our attempts to distinguish AHR WT by immunofluorescence using the Ahr −/− mouse as the negative control. Four different antibodies were therefore tried using WT and Ahr −/− livers as the positive and negative controls, respectively. The rabbit polyclonal anti-AHR from Enzo Life Sciences was found to be reliable by Western blot analysis and provided reliable immunofluorescence with results that paralleled published data [21]. However, the filamentous staining and the intense AHR signal in the WT lumen were previously unreported and supported the presence of AHR on the WT sperm flagella.
Our results also indicate that AHR plays a role in the formation of fully functional mature sperm. We present the first evidence that AHR is localized in the acrosome and the principal piece of the sperm flagellum. Staining of the sperm tails was observed both in isolated sperm and in testis cross-sections. Our qRT-PCR data also supports our conclusion that Ahr is expressed in mature sperm. Given that numerous drugs and other compounds have been found in human seminal fluid [53], AHR may contribute to xenobiotic metabolism in sperm and may be important for fertilization. For example, the AHR ligand TCDD can increase intracellular calcium concentration [54], which could affect sperm capacitation. Consistent with earlier studies noting no differences in the quantity of daily sperm production [23, 24], we also observed no differences in sperm quantity and motion parameters between Ahr−/− and WT mice. The relevance of these findings is uncertain given the high background rates of abnormal sperm in this study and in inbred strains [31]. Moreover, no standardized criteria exist for the evaluation of mouse sperm abnormalities such as the World Health Organization manual for human sperm analysis [55]. Nevertheless, when compared to WT, we found that Ahr−/− caudal sperm were less able to fertilize oocytes, indicating that AHR plays an important role in the development of fully functional sperm.
Our observations that loss of AHR results in decreased expression of genes involved in defense against reactive oxygen species (Ucp2, Sod2, and Nrf2) complement our previous results demonstrating that activation of AHR in spermatocytes leads to increased expression of these same family of genes [56]. In that study, cigarette smoke condensate (CSC), which contains numerous dioxin-like compounds, was used to activate AHR in spermatocytes. CSC treatment resulted in increased expression of Sod2 and Cyp1A1. Similarly, spermatocytes isolated by laser microdissection from mice treated with CSC demonstrated increased expression of Sod2, the glutathione antioxidant Gpx4, and the antioxidant uncoupling protein Ucp2 [56]. This body of work involving Ahr activation and now Ahr loss of function suggest that this signaling pathway may serve as a stress rheostat such that some degree of signaling is necessary for developmental homeostasis of male germ cells, however, overactivation leads to poor outcomes related to stress overload and an eventual inability to cope with excess stimulation. Further work in this area of reproductive toxicology will be necessary to discern the mechanisms responsible for the physiologic and pathologic roles that Ahr activation plays in male reproductive physiology.
ACKNOWLEDGMENT
The authors gratefully thank Dr. Deborah Frank for her suggestions and writing expertise.
REFERENCES
Notes
[5] Financial disclosure This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.